Survey finds medtechs lack confidence in regulatory data quality

Veeva medtech report reveals opportunity to move beyond manual processes for speed and compliance pleasanton, calif. , july 30, 2025 /prnewswire/ -- veeva systems (nyse: veev) today announced findings from the 2025 veeva medtech regulatory affairs benchmark, revealing that 50% of respondents lack full confidence in the completeness of their underlying data for global product registrations.
VEEV Ratings Summary
VEEV Quant Ranking